Aloprim (ALLOPURINOL)
Aloprim (ALLOPURINOL) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Aloprim; Generic name: ALLOPURINOL; Manufacturer: Mylan Institutional LLC.
| Brand name | Aloprim |
|---|---|
| Generic name | ALLOPURINOL |
| Manufacturer | Mylan Institutional LLC |
| Used for | 1 INDICATIONS AND USAGE ALOPRIM is indicated for the management of adult and pediatric patients with leukemia, lymphoma, and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels and who cannot tolerate oral therapy. ALOPRIM is a xanthine oxidase inhibitor indicated for the management of adult and pediatric patients with leukemia, lymphoma, and solid tumor malignancies who are receiving cancer therapy which causes elevations of serum and urinary uric acid levels and who cannot tolerate oral therapy. ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION • Recommended Dosage ( 2.2 ) Adult Patients 200 mg/m 2 /day to 400 mg/m 2 /day Maximum 600 mg/day Pediatric Patients Starting Dose 200 mg/m 2 /day Maximum 400 mg/day • Recommended Dosage in Adult Patients with Renal Impairment ( 2.2 , 5.2 , 8.6 ) Creatinine Clearance Recommended Daily Dose 10 to 20 mL/min 200 mg/day Less than 10 mL/min 100 mg/day On dialysis 50 mg every 12 hours, or 100 mg every 24 hours 2.1 Recommended Dosage Initiate therapy with ALOPRIM 24 to 48 ho |
| Active ingredient(s) | ALLOPURINOL SODIUM |
| Route | INTRAVENOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10cc918f-aa44-415b-932d-2404695ac449 |